EU Leaders Urge Funding of Critically-needed New Tools against Drug-resistant Tuberculosis - TB Alliance, TuBerculosis Vaccine Initiative and Deutsche Stiftung Weltbevölkerung High-Level Meeting - Seite 3

TuBerculosis Vaccine Initiative (TBVI)  

The TuBerculosis Vaccine Initiative (TBVI) is a non-profit foundation that facilitates the discovery and development of new, safe and effective TB vaccines that are accessible and affordable for all people.  As a Product Development Partnership (PDP), TBVI integrates, translates and prioritises R&D efforts to discover and develop new TB vaccines and biomarkers for global use. TBVI provides essential services that support the R&D efforts of its consortium partners - 50 partners from academia, research institutes and private industry in the TB vaccine field. For more information, please visit: http://www.tbvi.eu  

Deutsche Stiftung Weltbevölkerung (DSW)   

DSW focuses on the needs and potential of the largest youth generation in history. We are committed to creating demand for and access to health information, services and supplies, and to securing their right for a brighter future. We achieve this by engaging in gender sensitive advocacy, capacity development, and family planning initiatives. With our headquarters Germany, DSW maintains offices in Ethiopia, Kenya, Tanzania, and Uganda, as well as liaison offices in Berlin and Brussels. DSW also advocates for investment in research and innovation to fight poverty-related and neglected tropical diseases.

Contacts:
Thomas Lynch
[phone]
[e-mail]